DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Olsson LG, Swedberg K, Ducharme A et al.
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program.
J Am Coll Cardiol 2006;
47: 1997-2004
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.